SCHEMBL5495689

SCHEMBL5495689

CCNc1ccccc1C(=O)Nc1ccc2ncncc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.63
JAK1 P23458 2/20 0.63
KDR P35968 5/20 0.52
FLT1 P17948 2/20 0.52
AR P10275 1/20 0.51
EGFR P00533 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
NOTUM Q6P988 1/20 0.45
RXFP1 Q9HBX9 2/20 0.43
IMPDH2 P12268 1/20 0.42
KIT P10721 2/20 0.42
ABL1 P00519 1/20 0.42
CSF1R P07333 1/20 0.42
IGF1R P08069 1/20 0.42
PDGFRB P09619 1/20 0.42
FGFR1 P11362 1/20 0.42
FLT4 P35916 1/20 0.42
TEK Q02763 1/20 0.42
PABPC1 P11940 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24782968 0.76 EGFR (0.68) AREGFRNOTUMIMPDH2BRAF
SCHEMBL3953384 0.76 KDR (0.45) JAK2JAK1KDRFLT1AR
SCHEMBL27936888 0.76 AR (0.62) AREGFRNPC1RAB9ANOTUM
SCHEMBL28434934 0.76 NOTUM (0.58) AREGFRNOTUMIMPDH2
SCHEMBL5628546 0.75 CDC25B (0.50) AREGFRNOTUM
SCHEMBL5629016 0.74 MAPK8 (0.55) JAK2KDRFLT1AREGFR
SCHEMBL28451772 0.74 NOTUM (0.56) KDRAREGFRNPC1RAB9A
SCHEMBL5495693 0.74 MKNK1 (0.46) AREGFRBRAF
SCHEMBL12386087 0.73 MEN1 (0.59) JAK2JAK1NPC1RAB9A
SCHEMBL29985822 0.72 EGFR (0.61) AREGFRNPC1RAB9ANOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC. (US) 2007-09-26 EP disclosed
WO-2006039718-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2006-04-13 WO disclosed